Hemispherian raises the first tranche of a Series A to fund the development of its novel cancer therapeutics
/PRNewswire/ -- Hemispherian AS ("Hemispherian" or the "Company"), a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics...
Source: prnewswire.com